Table 1.
Biomarker-based evaluations | Classical | |||||
---|---|---|---|---|---|---|
| ||||||
τ* | τ*/pool size |
|
||||
Application 1 Se > 0.999; Sp > 0.999 | H(5: 1) | EFF (SD) | 0.426 (0.418) | 0.788 (0.492) | 0.426 (0.418) | 0.426 (0.418) |
PSE | 0.996 | >0.999 | 0.997 | >0.999 | ||
PSP | >0.999 | >0.999 | >0.999 | >0.999 | ||
PPV | >0.999 | >0.999 | >0.999 | >0.999 | ||
NPV | >0.999 | >0.999 | >0.999 | >0.999 | ||
| ||||||
H(8: 4: 1) | EFF (SD) | 0.391 (0.388) | 0.704 (0.450) | 0.393 (0.391) | 0.395 (0.389) | |
PSE | 0.986 | 0.999 | 0.993 | >0.999 | ||
PSP | >0.999 | >0.999 | >0.999 | >0.999 | ||
PPV | >0.999 | >0.999 | >0.999 | >0.999 | ||
NPV | 0.999 | >0.999 | >0.999 | >0.999 | ||
| ||||||
A(9 × 9) | EFF (SD) | 0.374 (0.115) | 0.835 (0.161) | 0.378 (0.116) | 0.380 (0.117) | |
PSE | 0.973 | 0.999 | 0.986 | >0.999 | ||
PSP | >0.999 | >0.999 | >0.999 | >0.999 | ||
PPV | >0.999 | >0.999 | >0.999 | >0.999 | ||
NPV | 0.999 | >0.999 | >0.999 | >0.999 | ||
| ||||||
Application 2 Se = 0.989; Sp = 0.980 | H(5: 1) | EFF (SD) | 0.337 (0.344) | 0.588 (0.487) | 0.458 (0.437) | 0.439 (0.426) |
PSE | 0.633 | 0.987 | 0.952 | 0.978 | ||
PSP | 0.998 | 0.983 | 0.991 | 0.996 | ||
PPV | 0.931 | 0.756 | 0.853 | 0.930 | ||
NPV | 0.981 | >0.999 | 0.997 | 0.999 | ||
| ||||||
H(8: 4: 1) | EFF (SD) | 0.258 (0.302) | 0.575 (0.424) | 0.406 (0.397) | 0.396 (0.387) | |
PSE | 0.513 | 0.986 | 0.920 | 0.967 | ||
PSP | 0.999 | 0.985 | 0.994 | 0.997 | ||
PPV | 0.947 | 0.776 | 0.894 | 0.948 | ||
NPV | 0.975 | 0.999 | 0.996 | 0.998 | ||
| ||||||
A(10 × 10) | EFF (SD) | 0.253 (0.053) | 0.751 (0.169) | 0.394 (0.121) | 0.385 (0.120) | |
PSE | 0.412 | 0.989 | 0.892 | 0.967 | ||
PSP | 0.999 | 0.981 | 0.994 | 0.997 | ||
PPV | 0.964 | 0.733 | 0.889 | 0.948 | ||
NPV | 0.970 | 0.999 | 0.994 | 0.998 |